Competition

  • March 30, 2026

    HPE Seeks Fix After States Expose Confidential Bidding Info

    Hewlett Packard Enterprise Co. urged a California federal judge to order a dozen states and Washington, D.C., to take corrective measures after they publicly filed thousands of pages of confidential documents related to the company's $14 billion acquisition of Juniper Networks Inc.

  • March 30, 2026

    5th Circ. Seems Open To Reviving Eyemart Class Action

    A Fifth Circuit panel seemed open to reviving a class action accusing glasses retailer Eyemart Express LLC of selling sensitive personal health information to social media giant Meta, asking Monday why dismissal was appropriate given the complexity of the case.

  • March 30, 2026

    Fla. Hospital System Patients Get Class Cert. Denied

    A Florida federal court refused to certify a class of consumers in a case accusing Health First Inc. of locking in patients and blocking competition from rival hospital systems, after finding a number of issues, including potential differences between proposed class members.

  • March 30, 2026

    Non-Wash. Landlords Escape Yardi Rent-Fixing Case

    A Washington federal judge on Monday tossed antitrust class action claims lodged against out-of-state multifamily landlords that were accused of running a rent price-fixing scheme that used property management software company Yardi Systems' technology, ruling that the court lacks personal jurisdiction over the out-of-state defendants.

  • March 30, 2026

    Calif. Judge Puts Nexstar-Tegna Merger On Ice During Review

    A California federal judge has blocked broadcast giants Nexstar and Tegna from combining operations in their $6.2 billion merger while a legal challenge from DirecTV moves forward, saying the satellite TV company showed irreparable harm could occur from the deal.

  • March 30, 2026

    5th Circ. Calls Pharmacy GLP-1 Args 'Tough Pills To Swallow'

    A Fifth Circuit panel pushed multiple compounding pharmacies to explain why they should get to compound lucrative drugs used for weight loss, including Ozempic, saying Monday that its options if it sides with the pharmacies are "tough pills to swallow."

  • March 30, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court's docket this past week featured disputes involving globally recognized companies, high-dollar contract fights, revived claims from the state's high court and the resolution of a closely watched de-SPAC case.

  • March 30, 2026

    Fastener Co. Can't Slip $17K TM Infringement Judgment

    A Pennsylvania federal judge has upheld a $17,000 trademark infringement judgment against industrial fastener company Peninsula Components after it was found liable for using its competitor Penn Engineering & Manufacturing Corp's "PEM" name in Google Ads, ruling that the defendant presented no compelling reason to erase the verdict.

  • March 30, 2026

    Colo. High Court Takes Up Netflix's Sales Tax Challenge

    The Colorado Supreme Court will determine whether Netflix's streaming video services are tangible personal property subject to sales tax, the justices said Monday, agreeing to review a state appeals court ruling in favor of the state Department of Revenue.

  • March 30, 2026

    FTC Says Anesthesia Group Cheered While Raising Prices

    The Federal Trade Commission pushed back against a bid from U.S. Anesthesia Partners to avoid facing trial on claims that it monopolized the market through a rollup strategy, saying the company celebrated its ability to dramatically increase prices.

  • March 30, 2026

    TriZetto's $70M Trade Secret Verdict Upheld, Total Award Cut

    A New York federal judge has upheld a $70 million compensatory damages verdict for the TriZetto Group in a long-running trade secret fight against Syntel Inc., while also cutting punitive damages to about $140 million and awarding TriZetto more than $12 million in attorney fees.

  • March 30, 2026

    Nationwide Need Not Cover Marker Makers' Trade Secret Fight

    Four Nationwide units have no duty to defend a marker manufacturer in an underlying suit by a competitor alleging it colluded with former employees to use trade secrets and other proprietary information, a Pennsylvania federal judge ruled.

  • March 27, 2026

    Live Nation Beat Rivals With Better Tech, Jury Hears

    A former executive for AEG Presents on Friday testified that his former employer's ticketing system was subpar to that of Live Nation's Ticketmaster, as counsel for the latter portrayed the live entertainment giant's dominant position in the market as a natural result of its superior services to clients.

  • March 27, 2026

    Networks Using Legacy TV As A 'Cash Cow,' Advocates Say

    Networks see local TV stations as little more than "cash cows" and are "sucking the lifeblood out of television stations" by demanding increasingly higher fees in exchange for allowing them to air network content, a pair of media advocacy groups have told the Federal Communications Commission.

  • March 27, 2026

    FCC Can't Waive TV Broadcast Cap For Nexstar, DC Circ. Told

    Public interest and labor groups banded together with cable and satellite groups Friday to try convincing the D.C. Circuit that the Federal Communications Commission can't waive its 39% national audience cap to let the $6.2 billion merger of Nexstar and Tegna Inc. move forward.

  • March 27, 2026

    Guests Ask High Court To Review Vegas Hotel Pricing Suit

    Las Vegas hotel guests are asking the U.S. Supreme Court to review a Ninth Circuit ruling that refused to revive their proposed class action accusing casino-hotel operators of using software from Cendyn Group to illegally inflate room rates.

  • March 27, 2026

    NC Biz Court Bulletin: Judge Exits, Duke Ducks Climate Suit

    The North Carolina Business Court saw an unexpected shakeup with one judge's retirement, rendered a pivotal decision in a first-of-its-kind climate change case against Duke Energy and oversaw a trial between the feuding owners of a commercial bed skirt company.

  • March 27, 2026

    Skull Shaver Can't Stop NJ Judge From Moving IP Suit To NC

    A New Jersey federal judge has adopted the recommendation of a magistrate judge who said Skull Shaver's patent infringement case against The Cut Buddy over electronic razor technology could move to North Carolina federal court.

  • March 27, 2026

    Berkshire RE Franchise Says 'Pied Piper' Lured Away Agents

    A Massachusetts franchise of Berkshire Hathaway's real estate unit alleged in a state court complaint Friday that the former sales manager of two offices outside Boston "acted as a corporate pied piper" to lure 21 colleagues to a competitor.

  • March 27, 2026

    EU's Ribera: Antitrust Must 'Stay Strong' Against Politics

    European Union antitrust chief Teresa Ribera had a word of caution Friday for competition enforcers who let political considerations influence their enforcement decisions, arguing in Washington, D.C., remarks that enforcement should remain stable against shifting political winds.

  • March 27, 2026

    CoStar Expands Mass Copyright Case Against Zillow

    Commercial real estate information company CoStar Group Inc. updated its mass copyright infringement suit against property listing company Zillow Group Inc. on Friday, now alleging in Washington federal court that Zillow stole more than 53,000 of CoStar's copyrighted property photos.

  • March 27, 2026

    Chanel Ducks The RealReal's Antitrust Counterclaims For Now

    A New York federal court has tossed antitrust counterclaims lodged against Chanel by used luxury goods retailer The RealReal after the fashion house accused it of selling counterfeit handbags.

  • March 27, 2026

    Judge Denies NAR Mandatory Membership Antitrust Claims

    A Louisiana federal judge has rejected an antitrust lawsuit brought pro se by a group of brokers claiming they are illegally forced to join a trio of real estate associations to access the Multiple Listing Service online home listing system.

  • March 27, 2026

    Apollo, BlackRock Deny Asking Kirkland To Abandon Optimum

    Apollo, Ares, BlackRock and other major financial companies have denied Optimum Communications' claims accusing them of "bullying" Kirkland & Ellis LLP into withdrawing as the telecommunications company's transaction counsel to get revenge for a collusion lawsuit filed in New York federal court.

  • March 27, 2026

    Kirkland-Led Transcend Bought By Otsuka In $1.2B Deal

    Clinical-stage biotechnology company Transcend Therapeutics Inc., led by Kirkland & Ellis LLP, Pillsbury Winthrop Shaw Pittman LLP and Goodwin Procter LLP, on Friday announced that it has agreed to be bought by Otsuka Pharmaceutical Co. Ltd. in a deal worth up to $1.225 billion.

Expert Analysis

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • A Changing Playbook For Fighting Records Requests In Del.

    Author Photo

    The Delaware Supreme Court's recent decision in Wong v. Amazon, reversing the denial of an inspection demand brought by a stockholder, serves as a stark warning to corporations challenging books and records requests, making clear that companies cannot defeat such demands solely by attacking the scope of their stated purpose, say attorneys at Duane Morris.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • FTC, CoStar Cases Against Zillow May Have Broad Impact

    Author Photo

    Zillow's partnerships with Redfin and Realtor.com have recently triggered dual fronts of legal scrutiny — an antitrust inquiry from the Federal Trade Commission and a mass copyright infringement suit from CoStar — raising complex questions that reach beyond real estate, says Shubha Ghosh at Syracuse University College of Law.

  • How 2nd Circ. Cannabis Ruling Upends NY Licensing

    Author Photo

    A recent Second Circuit decision in Variscite NY Four v. New York, holding that New York's extra-priority cannabis licensing preference for applicants with in-state marijuana convictions violates the dormant commerce clause, underscores that state-legal cannabis markets remain subject to the same constitutional constraints as other economic markets, say attorneys at Harris Beach.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • A Change In Big Pharma Response To FTC Delisting Warnings

    Author Photo

    While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.

  • 9th Circ. Finding That NFTs Are Goods Will Change TM Law

    Author Photo

    The Ninth Circuit's recent ruling in Yuga Labs v. Ripps establishes that NFTs have real, commercial value under U.S. federal trademark law, a new legal precedent that may significantly influence intellectual property enforcement and marketplace policies regarding digital assets going forward, say attorneys at Wilson Elser.

  • Series

    Adapting To Private Practice: From Texas AUSA To BigLaw

    Author Photo

    As I learned when I transitioned from an assistant U.S. attorney to a BigLaw partner, the move from government to private practice is not without its hurdles, but it offers immense potential for growth and the opportunity to use highly transferable skills developed in public service, says Jeffery Vaden at Bracewell.

  • Lessons From Liberty Mutual FCPA Declination

    Author Photo

    Liberty Mutual’s recent Foreign Corrupt Practices Act resolution with the U.S. Department of Justice signals that the Trump administration is once again considering such declinations after an enforcement pause, offering some assurances for companies regarding the benefits of voluntary self-disclosure, say attorneys at Paul Weiss.

  • Advice For 1st-Gen Lawyers Entering The Legal Profession

    Author Photo

    Nikki Hurtado at The Ferraro Law Firm tells her story of being a first-generation lawyer and how others who begin their professional journeys without the benefit of playbooks handed down by relatives can turn this disadvantage into their greatest strength.

  • FTC Focus: When Green Goals And Antitrust Law Collide

    Author Photo

    A recently concluded Federal Trade Commission investigation has turned an emissions deal involving major U.S. heavy-duty truck manufacturers that was brokered by the California Air Resources Board into a cautionary tale about the potential for environmental agreements to run afoul of competition rules, say attorneys at Proskauer.

  • Structuring Noncompetes In License And Collaboration Deals

    Author Photo

    As companies grappling with coming patent cliffs look to mergers and acquisitions to compensate, contracting parties assessing biopharma license and collaboration agreements should prepare to agree on noncompetes that ensure the parties' respective objectives are met and that their incentives are aligned, both under their collaboration and beyond, says Jeff Jay at Freshfields.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.